ABOS

Acumen Pharmaceuticals, Inc.—15-min delayed · EOD close

3.10 +6.16%as of 2026-09-02mkt cap $224M

Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001576885

Market cap

$224M

P/E

—

Net margin

—

ROE

-183.4%

Revenue

—

latest annual

Net income

−$105M

latest annual

Shares out

72.3M

Free cash flow

−$91.8M

3.10

Low

2.18

High

3.19

Quality score

—/100

Growth25

missing: revenueGrowth

Business qualityno data

missing: grossMargin, operatingMargin, netMargin

Financial health82

Valuationno data

missing: peRatio, psRatio

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.